To date, the impact of using alternative reference regions (RRs) on amyloid quantification has mainly been evaluated for semi-quantitative parameters [15–17]. Most alternative RRs have not been validated against the gold standard, i.e. full quantification with metabolite corrected plasma input curves or full quantification using a validated reference region.